An improved TLC method for investigation of the metabolic profile of BGYKI-38233--a new antiarrhythmic agent
Valkó, I.; Szepesi, G.
Die Pharmazie 45(4): 290
1990
ISSN/ISBN: 0031-7144 PMID: 2381982 Document Number: 349577
Document emailed within 1 workday
Related Documents
Gülker, H.; Thale, J.; Olbing, B.; Heuer, H.; Frenking, B.; Bender, F. 1985: Assessment of the antiarrhythmic profile of the new class i agent diprafenone Arzneimittel-Forschung 35(9): 1387-1393Sloskey, G.E. 1983: Amiodarone: a unique antiarrhythmic agent Clinical Pharmacy 2(4): 330-340
Borkowski, P.J. 1970: Bretylium tosylate as an antiarrhythmic agent Kardiologia Polska 13(2): 195-198
Laskawiec, G.; Zmudziński, J.; Jamrozik-Kruk, Z. 1993: Bepridil--a new antianginal agent with antiarrhythmic properties Polski Tygodnik Lekarski 48(14-15): 330-332
Kozák, P.; Stárek, A.; Hes, I.; Spacek, R. 1985: Propafenone--a new antiarrhythmic agent. Clinical experience Casopis Lekaru Ceskych 124(13): 407-410
Dvorák, K.; Vavros, B.; Cerný, J. 1975: Bretylium tosylate--a new antiarrhythmic agent with antifibrillatory effect Vnitrni Lekarstvi 21(3): 278-284
Lindstrom, T.D.; Lacefield, W.B.; Whitaker, G.W. 1984: Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(6): 691-697
Karapetian, A.E.; Gevorkian, R.A. 1972: Action of 4-methyluracil as an antiarrhythmic agent stimulating the growth of myocardial cells Farmakologiia i Toksikologiia 35(3): 297-299
Cheng, Y.N.; Kiyosue, T.; Arita, M. 1994: Effects of KT-362, a new antiarrhythmic agent, on membrane ionic currents of guinea pig ventricular myocytes Journal of Pharmacology and Experimental Therapeutics 270(3): 851-857
Beck, O.A.; Witt, E.; Hochrein, H. 1975: Effect of the antiarrhythmic agent propaphenone on cardiac conduction. clinical studies using bundle of his electrography Zeitschrift für Kardiologie 64(2): 179-187
Mertz, T.E.; Steffe, T.J. 1980: Pirmenol hydrochloride (CI-845): antiarrhythmic profile in coronary artery ligated conscious dogs Journal of Cardiovascular Pharmacology 2(5): 527-541
Jedrych, Z.; Borkowska, G. 1983: Investigation of new benzofurane, benzopiran and furanochromone derivatives--potential antiarrhythmic and hypotensive agents Polish Journal of Pharmacology and Pharmacy 35(5): 397-403
Fiset, C.; Drolet, B.; Hamelin, B.A.; Turgeon, J. 1997: Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class IIi antiarrhythmic drug dl-sotalol Journal of Pharmacology and Experimental Therapeutics 283(1): 148-156
Chen, C.L.; Sangiah, S.; Roder, J.D.; Chen, H.; Berlin, K.D.; Garrison, G.L.; Scherlag, B.J.; Lazzara, R. 1995: Pharmacokinetics and plasma protein binding of the new potent class IIi antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate Arzneimittel-Forschung 45(6): 670-675
Chen, C.L.; Sangiah, S.; Patterson, E.; Berlin, K.D.; Garrison, G.L.; Dunn, W.; Nan, Y.; Scherlag, B.J.; Lazzara, R. 1992: Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force Research Communications in Chemical Pathology and Pharmacology 78(1): 3-16
Irani, M. 1991: Efficacy and improved safety--a new anti-arthritic agent European Journal of Rheumatology and Inflammation 11(3): 43-49
Keller, F.; Feldmann, K.; Metz, F.J. 1981: An improved method for selective determination of serum albumin by the bromcresol green method, using the SMAR 12/60 Journal of Clinical Chemistry and Clinical Biochemistry 19(3): 169-171
Ente, B.H. 1990: Stimulating improved patient care: the Joint Commission's Agent for change Topics in Hospital Pharmacy Management 10(2): 22-30
Park, Y.; Kwon, H.-Y.; Shimi, M.K.; Rhyu, M.-r.; Lee, Y. 2011: Improved lipid profile in ovariectomized rats by red ginseng extract Die Pharmazie 66(6): 450-453
Murakami, M.; Kinukawa, M.; Kanazawa, T.; Maruyama, K.; Miyagi, M.; Miyata, H.; Ujiie, A. 1996: Effects of the new class i antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity Journal of Pharmacology and Experimental Therapeutics 279(2): 877-883